AR029189A1 - Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento - Google Patents

Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento

Info

Publication number
AR029189A1
AR029189A1 ARP000105742A ARP000105742A AR029189A1 AR 029189 A1 AR029189 A1 AR 029189A1 AR P000105742 A ARP000105742 A AR P000105742A AR P000105742 A ARP000105742 A AR P000105742A AR 029189 A1 AR029189 A1 AR 029189A1
Authority
AR
Argentina
Prior art keywords
separately
inhibitor
phosphodiesterase
preparation
inflammatory
Prior art date
Application number
ARP000105742A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR029189A1 publication Critical patent/AR029189A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP000105742A 1999-11-02 2000-10-31 Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento AR029189A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
AR029189A1 true AR029189A1 (es) 2003-06-18

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105742A AR029189A1 (es) 1999-11-02 2000-10-31 Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento

Country Status (29)

Country Link
EP (1) EP1225866A4 (hu)
JP (1) JP2003513028A (hu)
KR (1) KR20020057988A (hu)
CN (1) CN1387404A (hu)
AP (1) AP2002002496A0 (hu)
AR (1) AR029189A1 (hu)
AU (1) AU1357501A (hu)
BG (1) BG106748A (hu)
BR (1) BR0015270A (hu)
CA (1) CA2388333A1 (hu)
CO (1) CO5261512A1 (hu)
CZ (1) CZ20021512A3 (hu)
DZ (1) DZ3225A1 (hu)
EA (1) EA200200518A1 (hu)
EC (1) ECSP003747A (hu)
HK (1) HK1049107A1 (hu)
HU (1) HUP0203152A3 (hu)
IL (1) IL149367A0 (hu)
MA (1) MA26841A1 (hu)
MX (1) MXPA02004350A (hu)
NO (1) NO20022057L (hu)
OA (1) OA12076A (hu)
PE (1) PE20011005A1 (hu)
PL (1) PL355261A1 (hu)
SK (1) SK7592002A3 (hu)
TR (1) TR200201211T2 (hu)
TW (1) TWI242431B (hu)
WO (1) WO2001032127A2 (hu)
ZA (1) ZA200203435B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100496607C (zh) 2001-09-19 2009-06-10 尼科梅德有限责任公司 Nsaid与pde-4抑制剂的并用药物
MXPA04003668A (es) * 2001-10-31 2004-07-22 Merck Patent Gmbh Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
WO2004087149A1 (ja) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co. Ltd. 医薬組成物
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (en) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
CN104338219B (zh) 2010-01-05 2017-10-24 微剂量治疗技术公司 吸入设备和方法
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2229221T3 (es) * 1993-06-18 2005-04-16 Smithkline Beecham Corporation Procedimiento de identificacion de un inhibidor de pde iv.
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
JP2003513028A (ja) 2003-04-08
BR0015270A (pt) 2002-06-18
HUP0203152A3 (en) 2004-06-28
CA2388333A1 (en) 2001-05-10
AP2002002496A0 (en) 2002-06-30
HUP0203152A2 (hu) 2003-01-28
CN1387404A (zh) 2002-12-25
NO20022057L (no) 2002-06-27
PE20011005A1 (es) 2001-09-28
PL355261A1 (en) 2004-04-05
OA12076A (en) 2006-05-04
KR20020057988A (ko) 2002-07-12
NO20022057D0 (no) 2002-04-30
DZ3225A1 (fr) 2001-05-10
WO2001032127A2 (en) 2001-05-10
EA200200518A1 (ru) 2002-10-31
TWI242431B (en) 2005-11-01
SK7592002A3 (en) 2002-11-06
EP1225866A4 (en) 2004-04-21
MA26841A1 (fr) 2004-12-20
HK1049107A1 (zh) 2003-05-02
ECSP003747A (es) 2002-05-23
BG106748A (en) 2003-02-28
EP1225866A2 (en) 2002-07-31
TR200201211T2 (tr) 2002-08-21
CO5261512A1 (es) 2003-03-31
IL149367A0 (en) 2002-11-10
WO2001032127A3 (en) 2001-12-06
CZ20021512A3 (cs) 2003-04-16
MXPA02004350A (es) 2002-11-07
AU1357501A (en) 2001-05-14
ZA200203435B (en) 2003-06-25

Similar Documents

Publication Publication Date Title
DE60114571D1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
AR013506A1 (es) Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
BR0005299A (pt) Compostos para o tratamento de disfução sexual feminina
ID29181A (id) Kombinasi formoterol dan garam tiotropium
AR037255A1 (es) Composiciones farmaceuticas que contienen oxibutinina
YU106192A (sh) Nova kombinacija bronhodilatatora i steroidnog antiinflamatornog leka za lečenje respiratornih poremećaja
BR0306513A (pt) tampão com medicamento
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
AR029189A1 (es) Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento
BR9908617A (pt) Nitroto inorgânico e ácido orgânico em combinação como uma composição antiviral tópica.
AR026197A1 (es) Uso de dipiridamol o mopidamol para el tratamiento y prevencion de trastornos de la microcirculacion dependientes de fibrina
BR0007613A (pt) Aplicação de imidazo[1,5-a]-pirido[3,2-e]-pirazinonascomo medicamento
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
BR0109747A (pt) Uso de 5-(2-pirazinil)-4-metil-1-2-ditiol-3-tiona (oltipraz) como um medicamento, composição farmacêutica para a prevenção e tratamento da progressão da fibrose hepática, uso de 5-(2-pirazinil)-4-metil-1, 2-ditiol-3-tiona e método para a prevenção e tratamento da progressão da fibrose e da cirrose hepática
WO2004094373A3 (en) A method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith
CR8584A (es) Piperazinas derivadas de urea para el tratamiento de la endometrosis
AR010432A1 (es) Composiciones farmaceuticas que contienen acido ricinoleico y su uso para la terapia antiinflamatoria y analgesica
AR034036A1 (es) Inhibidor de aromatasa en una dosis unica para tratar la infertilidad
PT927031E (pt) Composicao farmaceutica que contem nimesulide para administracao por via oral
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
WO2001001995A3 (en) Method for treatment of asthma syndrome
BRPI0509305A (pt) uso de um sensibilizador insulìnico, composição farmecêutica, e , kit

Legal Events

Date Code Title Description
FA Abandonment or withdrawal